Allison Luo
Hoofd Techniek/Wetenschap/O&O bij PROMETHEUS BIOSCIENCES, INC.
Actieve functies van Allison Luo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2018 | - |
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-06-2017 | - |
Loopbaan van Allison Luo
Eerdere bekende functies van Allison Luo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Directeur/Bestuurslid | 01-09-2006 | 01-10-2014 |
| IVERIC BIO, INC. | Corporate Officer/Principal | 01-09-2015 | - |
| ABBOTT LABORATORIES | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Allison Luo
| Northwestern University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Bedrijven in privébezit | 2 |
|---|---|
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Beurs
- Insiders
- Allison Luo
- Ervaring
